Clinical & Translational Research
Community & Public Health
Basic Sciences
Clinical & Translational Sciences
Meharry Shared Resources
Collaborative Institutional Resources
Meharry Medical College has several multi-institutional grants and partnerships that expand our research capabilities through collaborations with universities, non-profits, government agencies, and community organizations.
The Meharry-Vanderbilt Alliance develops and supports collaborative initiatives. It has provided opportunities for collaboration between Meharry Medical College and Vanderbilt University Medical Center, and for collaboration with projects in the community. The MVA focuses on research, interprofessional education, community engagement, and supports a student alliance.
Executive Director
Meharry-Vanderbilt Alliance
Administrative Director
Meharry-Vanderbilt Alliance
The Tennessee Center for AIDS Research (TN-CFAR) leverages complementary strengths of its four partner institutions to have broad and substantial impact on the HIV epidemic. Through this four-way partnership between Vanderbilt University Medical Center, Meharry Medical College, the Tennessee Department of Health, and Nashville CARES, our vision is to have transformative, local and global translational impact. Guided by this vision, our mission is to coordinate the institutional and community strengths and resources of VUMC, MMC, TDH and CARES to most effectively reduce the burden of HIV/AIDS and generalize these benefits worldwide.
Founded in 2000 by funding from the National Cancer Institute, Meharry Medical College and Vanderbilt-Ingram Cancer Center launched the MMC-VICC Cancer Partnership. The program expanded in 2006 to include Tennessee State University, creating the current Meharry-Vanderbilt-TSU Cancer Partnership. The program balances focus on population science, basic research, and clinical research to strengthen and expand cancer research.
Chair, Dept. of Biochemistry and Cancer Biology & Professor
School of Medicine
Professor, Emeritus Director, Vanderbilt-Ingram Comprehensive Cancer Center
Vanderbilt University
Professor of Cancer Biology, Cell & Developmental Biology, and Medicine
Vanderbilt University Medical Center
Research Professor & Emeritus Director, Center for Prevention Research
Tennessee State University
Professor, Department of Chemistry
Tennessee State University
Program Coordinator, Associate Director of Research Administration
Vanderbilt-Ingram Cancer Center
Since 2007, Meharry has been partner with the Vanderbilt Institute for Clinical and Translational Research (VICTR), Vanderbilt’s virtual home for clinical and translational research. Supported by the Vanderbilt University Medical Center’s Office of Research and the NIH sponsored Clinical and Translational Science Award (CTSA), the mission of the institute is to transform the way ideas and research discoveries make their way from origin to patient care. VICTR provides tools and support to improve the quality of research, publications, grant writing, and training for future doctors and researchers.
Executive Vice President For Research, Senior Associate Dean For Clinical Sciences, Melinda Owen Bass Professor Of Medicine
Vanderbilt University Medical Center
Vice President For Health Equity (VUMC), Associate Dean For Health Equity (Vanderbilt SOM), Executive Director (Meharry-Vanderbilt Alliance), Engagement Core Director (All Of Us Research Program )
Vanderbilt University Medical Center
Research Associate Professor of Medicine
Vanderbilt University Medical Center
Genomics-informed drug-repurposing strategy identifies two therapeutic targets for preventing liver disease associated with metabolic dysfunction.
Hannah M Seagle, Alexis T Akerele, Joseph A DeCorte, Jacklyn N Hellwege, Joseph H Breeyear, Jeewoo Kim, Michael G Levin, Samuel Khodursky, Adam Bress, Kyung Min Lee, Jens Meiler, Dipender Gill, Jennifer S Lee, Kent Heberer, Donald R Miller, Peter D Reaven, Kyong-Mi Chang, Julie A Lynch, Nikhil K Khankari, Megan M Shuey, Todd L Edwards, Marijana Vujkovic
Hydroxypropyl-Beta-Cyclodextrin (HP-BCD) inhibits SARS-CoV-2 replication by modulating intracellular lipid dynamics and preventing viral replication complex formation.
Bruno Braz Bezerra, Keylla Vitória Gomes Macedo, Isadora Alonso Correa, Sharton Vinicius Antunes Coelho, Marcos Romario Matos de Souza, Barbara Martins Cordeiro, Carlos Frederico Leite Fontes, Fabiana Avila Carneiro, Flavio Matassoli, Luciana Jesus Costa, James E K Hildreth, Luciana Barros Arruda
Priapism Before and After Hematopoietic Stem Cell Therapy in Individuals with Sickle Cell Disease.
Jose A Mejias, Santosh L Saraf, Clifford M Takemoto, Mark Rodeghier, Michael R DeBaun
Perlecan is a novel target of autoantibodies in anti-glomerular basement membrane disease.
Huang Kuang, Bei-Ning Wang, Xiao- Yu Jia, Zhao Cui, Xiao-Juan Yu, Nan Jiang, Dorin-Bogdan Borza, Ming-Hui Zhao
Haplo-stem cell transplant post liver transplantation to cure sickle cell disease with related liver dysfunction: a case series.
Ali D Alahmari, Saad Alghamdi, Reem Alasbali, Sara Hisham Samarkandi, Saleh Algahtani, Hadeel Samarkandi, Syed Osman Ahmed, Dieter Broering, Hazzaa Alzahrani, Adetola Kassim, Mahmoud Aljurf, Fahad Almohareb, Waleed Al-Hamoudi
Improving automated deep phenotyping through large language models using retrieval-augmented generation.
Brandon T Garcia, Lauren Westerfield, Priya Yelemali, Nikhita Gogate, E Andres Rivera-Munoz, Haowei Du, Moez Dawood, Angad Jolly, James R Lupski, Jennifer E Posey